PATENT CLAIM ANALYSIS

Application Number: 15876698
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "278000"]

Abstract:
The present invention provides, in part, heterocyclic spiro compounds of Formula I: and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating MAGL-mediated diseases and disorders including, e.g., pain, an inflammatory disorder, depression, anxiety, Alzheimer's disease, a metabolic disorder, stroke, or cancer.

Claim (Index 5):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein ring A 1  is C 4-6  cycloalkyl or 4- to 6-membered heterocycloalkyl.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 86.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15874987', '15221658', '14902324', '15808242', '11127878']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7891699278848961
- 35 USC 102 Novelty (BERT): 0.5534661739419298
- Combined Prediction Score: 0.7655995524905995
- Mean Citation Score: 371.852396
- Max Citation Score: 404.64084
- Similarity Product: 321.9785826953745

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test